Back

Clinical practice in left atrial appendage closure with focus on antithrombotic therapy: results from a European Heart Rhythm Association survey

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Left atrial appendage closure Left Atrial Appendage Closure EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Lukas Urbanek

Cardioangiologisches Centrum Bethanien, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
Outcomes for haemorrhagic transformation patients treated with left atrial appendage occlusion
Professor A. Sabbag (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Risk of cerebrovascular events in patients after left atrial appendage closure: results from large, real-world dataset
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Application of deep learning models to transesophageal echocardiography images for percutaneous left atrial appendage closure
Doctor R. Tateishi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Temporal morphological changes of the left atrial appendage after electrical isolation: implications for optimal timing of LAA occlusion
Doctor M. Tanaka (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Mechanical thrombus aspiration as a bailout strategy for device related thrombus after LAAC
Doctor V. La Fazia (Austin, US)
Abstract Slides Video

Access the full session

Session thumbnail
Left atrial appendage closure

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Joining forces for gender equity in interventional cardiology: results of a national survey in Portugal.
thumbnail
Congress Presentation
Sex-specific effects of apixaban versus aspirin in subclinical atrial fibrillation: insights from the ARTESiA trial
thumbnail
Congress Presentation
Real-world outcomes of oral anticoagulation in atrial fibrillation patients with high bleeding and stroke risks: evidence from three international registries from Middle East, Europe and Asia-Pacific

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources